Overview
Oya Tugal is a Hematologist and an Oncologist in Hawthorne, New York. Dr. Tugal is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Lymphoblastic Leukemia (ALL), and Sickle Cell Disease.
Her clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
19 Bradhurst Avenue, Hawthorne, NY 10532
Additional Areas of Focus
Dr. Tugal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.
Trustees Of Columbia University In The City Of New York
Antonio Fojo is an Oncologist in New York, New York. Dr. Fojo is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma.
Yale University
Hari Deshpande is an Interventional Cardiologist and an Oncologist in New Haven, Connecticut. Dr. Deshpande is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Desmoid Tumor, Liposarcoma, Alveolar Soft Part Sarcoma, and Gastrostomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Tugal isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Experienced
- Acquired AgranulocytosisDr. Tugal isExperienced. Learn about Acquired Agranulocytosis.
- Acute Lymphoblastic Leukemia (ALL)Dr. Tugal isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Promyelocytic LeukemiaDr. Tugal isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adrenal CancerDr. Tugal isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Tugal isExperienced. Learn about Agranulocytosis.